How COVID-19-related stressors altered drunkenness frequency.
A startup backed by Nobel winner David Baker takes an AI twist on antibodies
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS